Back
Las Vegas Sands Vs. Monopar Therapeutics Industry Stock Comparison
Buy
61
LVS
Las Vegas Sands
Last Price:
52.25
Seasonality Move:
2.5%
Buy
75
MNPR
Monopar Therapeutics
Last Price:
31.32
Seasonality Move:
35.55%
Buy
61
Las Vegas Sands (LVS)
is a Buy
Is Las Vegas Sands a Buy, Sell or Hold?
- The current Las Vegas Sands [LVS] share price is $53.64. The Score for LVS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- LVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LVS Stock Price Chart
What is Las Vegas Sands's stock price today?
-
The Las Vegas Sands share price today is $53.64
The current trend is moderately bearish and LVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.86 | Buy |
Relative Strength Index (14 RSI): | 55.43 | Buy |
Chaikin Money Flow: | 4757974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.69 - 54.31) | Buy |
Bollinger Bands (100): | (40.7 - 52.82) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.92 | Buy |
Relative Strength Index (14 RSI): | 76.63 | Buy |
Chaikin Money Flow: | 62338 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.5 - 24.7) | Buy |
Bollinger Bands (100): | (1.59 - 18.41) | Buy |
LVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.04 | Sell |
20-day SMA: | 52.78 | Buy |
50-day SMA: | 51.92 | Buy |
200-day SMA: | 46.7 | Buy |
8-day EMA: | 53.65 | Sell |
20-day EMA: | 52.99 | Buy |
50-day EMA: | 51.14 | Buy |
200-day EMA: | 48 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.74 | Buy |
20-day SMA: | 22.43 | Buy |
50-day SMA: | 16.57 | Buy |
200-day SMA: | 6.79 | Buy |
8-day EMA: | 25.62 | Buy |
20-day EMA: | 22.75 | Buy |
50-day EMA: | 17.67 | Buy |
200-day EMA: | 9.07 | Buy |
Las Vegas Sands Earnings Growth & LVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.41 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.
Las Vegas Sands Technical Analysis
Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |